JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lonsberry, B. B.
Right arrow Articles by Pierce, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lonsberry, B. B.
Right arrow Articles by Pierce, G. N.

Effect of chronic administration of verapamil on Ca++ channel density in rat tissue

BB Lonsberry, MP Czubryt, DF Dubo, JS Gilchrist, JC Docherty, TG Maddaford and GN Pierce

Ion Transport Laboratory, St. Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada.

The purpose of this study was to determine if chronic administration of verapamil could alter the density of Ca++ channels in the heart as determined by [3H]PN 200-110 binding. Initially, we compared the effects of verapamil given by s.c. injection or via implantable, slow- release verapamil pellets. We found the majority of animals treated with the pellets died within 24 hr. Those that survived exhibited significantly depressed maximal binding and Kd values for PN 200-110 binding to cardiac membranes, but binding to brain membranes was unaffected. Quantitation of the serum levels of verapamil and its metabolites by high-performance liquid chromatography demonstrated that the verapamil pellets did not release the drug evenly over a 3-week period. Most of the drug was released in toxic quantities during the 1st day after implantation. Verapamil administered by injection (2.5-30 mg/kg/day) for up to 16 weeks raised plasma verapamil levels to 25 to 250 ng/ml, but had no effect on Ca++ channel characteristics in cardiac or brain tissue. The maximal binding and Kd values for skeletal muscle PN 200-110 binding were increased only at the highest dosage for 8 weeks duration. Our results demonstrate that implantable pellets are not a reliable administration method for verapamil and cardiac Ca++ channels are highly resistant to change during chronic verapamil administration.

Volume 263, Issue 2, pp. 540-545, 11/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
A. J Workman, K. A Kane, J. A Russell, J. Norrie, and A. C Rankin
Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling
Cardiovasc Res, June 1, 2003; 58(3): 518 - 525.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. Bowling, W. E. Bloomquist, M. L. Cohen, H. U. Bryant, H. W. Cole, D. E. Magee, E. R. Rowley, and C. J. Vlahos
Effects of Prolonged Ethinyl Estradiol Treatment on Calcium Channel Binding and In Vivo Calcium-Mediated Hemodynamic Responses in Ovariectomized Rats
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 218 - 225.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics.